1999
DOI: 10.1177/0310057x9902700217
|View full text |Cite
|
Sign up to set email alerts
|

Subcutaneous Nodules with Pseudomas Septicaemia in an Immunocompetent Patient

Abstract: Pseudomonas septicaemia presenting with subcutaneous nodules, though rare, is well described in immuno-compromized populations. It is, however, very uncommon in immunocompetent patients. We describe a case of a 42-year-old woman who presented with community-acquired Pseudomonas aeruginosa septicaemia and subcutaneous nodules. No precipitating cause or immune dysfunction was found. She was successfully treated with appropriate antibiotics, respiratory and cardiovascular support in the Intensive Care Unit. The d… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2011
2011
2022
2022

Publication Types

Select...
1
1

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(1 citation statement)
references
References 10 publications
0
1
0
Order By: Relevance
“…According to some cases 2,3 , community-acquired P. aeruginosa may cause severe aggressive infections in healthy children. 25% of fatal cases were found to carry novel pathogenic variants in PID genes by exome/genome sequencing in previously healthy children 4 . X-linked hyper-IgM syndrome (XHIGM; HIGM1; OMIM:308230) is one type of primary immunodeficiency disease(PIDs), resulting from defects in the CD40 ligand/CD40 signaling pathways leading to impairment of immunoglobulin isotype switching in B cells.…”
Section: Introductionmentioning
confidence: 99%
“…According to some cases 2,3 , community-acquired P. aeruginosa may cause severe aggressive infections in healthy children. 25% of fatal cases were found to carry novel pathogenic variants in PID genes by exome/genome sequencing in previously healthy children 4 . X-linked hyper-IgM syndrome (XHIGM; HIGM1; OMIM:308230) is one type of primary immunodeficiency disease(PIDs), resulting from defects in the CD40 ligand/CD40 signaling pathways leading to impairment of immunoglobulin isotype switching in B cells.…”
Section: Introductionmentioning
confidence: 99%